Crimean-Congo hemorrhagic fever virus infection is lethal for adult type I interferon receptor-knockout mice
- PMID: 20164263
- DOI: 10.1099/vir.0.019034-0
Crimean-Congo hemorrhagic fever virus infection is lethal for adult type I interferon receptor-knockout mice
Abstract
Crimean-Congo hemorrhagic fever virus (CCHFV) poses a great threat to public health due to its high mortality, transmission and geographical distribution. To date, there is no vaccine or specific treatment available and the knowledge regarding its pathogenesis is highly limited. Using a small-animal model system, this study showed that adult mice missing the type I interferon (IFN) receptor (IFNAR(-/-)) were susceptible to CCHFV and developed an acute disease with fatal outcome. In contrast, infection of wild-type mice (129 Sv/Ew) was asymptomatic. Viral RNA was found in all analysed organs of the infected mice, but the amount of CCHFV RNA was significantly higher in the IFNAR(-/-) mice than in the wild-type mice. Furthermore, the liver of IFNAR(-/-) mice was enlarged significantly, showing that IFN is important for limiting virus spread and protecting against liver damage in mice.
Similar articles
-
Hazara virus infection is lethal for adult type I interferon receptor-knockout mice and may act as a surrogate for infection with the human-pathogenic Crimean-Congo hemorrhagic fever virus.J Gen Virol. 2012 Mar;93(Pt 3):560-564. doi: 10.1099/vir.0.038455-0. Epub 2011 Nov 16. J Gen Virol. 2012. PMID: 22090213
-
Nucleoside-Modified mRNA Vaccines Protect IFNAR-/- Mice against Crimean-Congo Hemorrhagic Fever Virus Infection.J Virol. 2022 Feb 9;96(3):e0156821. doi: 10.1128/JVI.01568-21. Epub 2021 Nov 24. J Virol. 2022. PMID: 34817199 Free PMC article.
-
Immunization with DNA Plasmids Coding for Crimean-Congo Hemorrhagic Fever Virus Capsid and Envelope Proteins and/or Virus-Like Particles Induces Protection and Survival in Challenged Mice.J Virol. 2017 Apr 28;91(10):e02076-16. doi: 10.1128/JVI.02076-16. Print 2017 May 15. J Virol. 2017. PMID: 28250124 Free PMC article.
-
Crimean-Congo hemorrhagic fever.Antiviral Res. 2004 Dec;64(3):145-60. doi: 10.1016/j.antiviral.2004.08.001. Antiviral Res. 2004. PMID: 15550268 Review.
-
Recent advances in understanding Crimean-Congo hemorrhagic fever virus.F1000Res. 2018 Oct 29;7:F1000 Faculty Rev-1715. doi: 10.12688/f1000research.16189.1. eCollection 2018. F1000Res. 2018. PMID: 30416710 Free PMC article. Review.
Cited by
-
Lethal Crimean-Congo hemorrhagic fever virus infection in interferon α/β receptor knockout mice is associated with high viral loads, proinflammatory responses, and coagulopathy.J Infect Dis. 2013 Jun 15;207(12):1909-21. doi: 10.1093/infdis/jit061. Epub 2013 Feb 15. J Infect Dis. 2013. PMID: 23417661 Free PMC article.
-
Viral infections in humans and mice with genetic deficiencies of the type I IFN response pathway.Eur J Immunol. 2021 May;51(5):1039-1061. doi: 10.1002/eji.202048793. Epub 2021 Apr 4. Eur J Immunol. 2021. PMID: 33729549 Free PMC article. Review.
-
Nucleocapsid protein-based vaccine provides protection in mice against lethal Crimean-Congo hemorrhagic fever virus challenge.PLoS Negl Trop Dis. 2018 Jul 16;12(7):e0006628. doi: 10.1371/journal.pntd.0006628. eCollection 2018 Jul. PLoS Negl Trop Dis. 2018. PMID: 30011277 Free PMC article.
-
Animal Models for Crimean-Congo Hemorrhagic Fever Human Disease.Viruses. 2019 Jun 28;11(7):590. doi: 10.3390/v11070590. Viruses. 2019. PMID: 31261754 Free PMC article. Review.
-
Sequential determination of serum viral titers, virus-specific IgG antibodies, and TNF-α, IL-6, IL-10, and IFN-γ levels in patients with Crimean-Congo hemorrhagic fever.BMC Infect Dis. 2014 Jul 28;14:416. doi: 10.1186/1471-2334-14-416. BMC Infect Dis. 2014. PMID: 25066751 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources